StockData
Eton Pharmaceuticals, Inc. logo

Eton Pharmaceuticals, Inc. (ETON) stock

ETONNasdaqPharmaceutical PreparationsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 5, 2026Score 10/30521% above fair value
$63.65−0.23 (-0.36%)

Close on Nov 17, 2026Market cap $1.82BP/E 163.2Yield –

Eton Pharmaceuticals r&d expenses

Research and development expenses are spending on new products and technology.

Eton Pharmaceuticals's R&D Expenses for the twelve months ending Jun 30, 2026 was $5.76M. For fiscal 2025 it was $7.77M, up 138.6% from the year before. The highest annual figure on record is $14.10M in fiscal 2020.

Annual r&d expenses

PeriodPeriod endValueChange
FY2025Dec 31, 2025$7.77M+138.6%
FY2024Dec 31, 2024$3.26M-2.0%
FY2023Dec 31, 2023$3.32M-16.9%
FY2022Dec 31, 2022$4.00M-35.9%
FY2021Dec 31, 2021$6.24M-55.8%
FY2020Dec 31, 2020$14.10M+22.1%
FY2019Dec 31, 2019$11.56M+105.3%
FY2018Dec 31, 2018$5.63M–

Quarterly r&d expenses

Change is against the same quarter a year earlier.

PeriodPeriod endValueChange
Q2 FY2026Jun 30, 2026$993.00K-73.2%
Q1 FY2026Mar 31, 2026$1.88M+61.5%
Q4 FY2025Dec 31, 2025$1.78M+252.5%
Q3 FY2025Sep 30, 2025$1.11M-62.6%
Q2 FY2025Jun 30, 2025$3.71M+470.2%
Q1 FY2025Mar 31, 2025$1.16M+10.9%
Q3 FY2024Sep 30, 2024$505.00K-17.9%
Q2 FY2024Jun 30, 2024$2.97M+164.0%
Q1 FY2024Mar 31, 2024$651.00K+21.7%
Q4 FY2023Dec 31, 2023$1.05M+10.9%
Q3 FY2023Sep 30, 2023$615.00K-17.3%
Q2 FY2023Jun 30, 2023$1.13M+63.0%
Q1 FY2023Mar 31, 2023$535.00K-66.9%
Q4 FY2022Dec 31, 2022$944.00K+38.6%
Q3 FY2022Sep 30, 2022$744.00K-72.2%
Q2 FY2022Jun 30, 2022$690.00K-65.3%
Q1 FY2022Mar 31, 2022$1.62M+82.6%
Q4 FY2021Dec 31, 2021$681.00K-80.0%
Q3 FY2021Sep 30, 2021$2.68M-5.2%
Q2 FY2021Jun 30, 2021$1.99M+23.7%
Q1 FY2021Mar 31, 2021$886.00K-85.9%
Q4 FY2020Dec 31, 2020$3.40M+1359.7%
Q3 FY2020Sep 30, 2020$2.83M-17.3%
Q2 FY2020Jun 30, 2020$1.61M+11.8%
Q1 FY2020Mar 31, 2020$6.27M-3.0%
Q4 FY2019Dec 31, 2019$233.00K-78.9%
Q3 FY2019Sep 30, 2019$3.42M+121.4%
Q2 FY2019Jun 30, 2019$1.44M-15.7%
Q1 FY2019Mar 31, 2019$6.47M+407.5%
Q4 FY2018Dec 31, 2018$1.10M-29.5%
Q3 FY2018Sep 30, 2018$1.54M–
Q2 FY2018Jun 30, 2018$1.71M–
Q1 FY2018Mar 31, 2018$1.27M–
Q3 FY2017Sep 30, 2017$1.56M–

More Eton Pharmaceuticals figures

See a number that looks wrong?